Strømme syndrome | |
---|---|
Other names | Stromme syndrome, apple-peel intestinal atresia–ocular anomalies–microcephaly syndrome, [1] jejunal atresia–microcephaly–ocular anomalies syndrome, [1] apple peel syndrome with microcephaly and ocular anomalies, [2] jejunal atresia with microcephaly and ocular anomalies, [2] (formerly) primary ciliary dyskinesia 31 (CILD31) [2] |
![]() | |
Female infant with Strømme syndrome showing microcephaly | |
Pronunciation |
|
Specialty | Medical genetics ![]() |
Symptoms | Apple-peel intestinal atresia, underdeveloped eyes, microcephaly with developmental delay; sometimes additional symptoms or fewer symptoms [2] [3] |
Causes | Genetic (autosomal recessive mutation in CENPF ) [2] [3] |
Diagnostic method | Based on symptoms, genetic testing [4] |
Prognosis | Not yet certain. Good for most, though perinatal mortality possible in the most severe cases. [3] [4] |
Frequency | Not yet known. Around 13 individuals diagnosed as of 2017 [update] . [2] |
Strømme syndrome is a very rare autosomal recessive genetic condition characterised by intestinal atresia (in which part of the intestine is missing), eye abnormalities and microcephaly. The intestinal atresia is of the "apple-peel" type, in which the remaining intestine is twisted around its main artery. The front third of the eye is typically underdeveloped, and there is usually moderate developmental delay. Less common features include an atrial septal defect, increased muscle tone or skeletal abnormalities. [2] [3] Physical features may include short stature, large, low-set ears, a small jaw, a large mouth, epicanthic folds, or fine, sparse hair. [2] [3] [5]
The syndrome is caused by mutations in both copies of the CENPF gene, which codes for centromere protein F. [2] [3] This protein is involved in cell division, in which it forms part of a disc-shaped protein complex known as a kinetochore. CENPF also has a role in orienting long, cylindrical structures called microtubules to form thin cell protrusions called cilia, which send and receive signals to trigger cell division, migration or differentiation. Mutations in the gene result in slower cell division and some embryonic developmental processes being disrupted or not completed, and the syndrome can be classified as a ciliopathy. [2] [6] [7] The syndrome is typically diagnosed based on the symptoms, but genetic testing provides a full confirmation. [4] [7]
Treatment centres around the symptoms. The intestinal atresia is usually surgically correctable in infancy with anastomosis. [3] The prognosis is not yet certain. Those who have survived birth and infancy (the majority) have continued to live through childhood and adolescence, but a large minority with the most severe cases have died before or shortly after birth. [2] [3] [4]
The prevalence is not yet known. As of 2017 [update] , around 13 individuals had been diagnosed. [2] The syndrome was first identified based on symptoms in two siblings by Norwegian paediatrician Petter Strømme and his associates in 1993. [2] [8] It was named after him in a 2008 study describing another patient. [2] [9] In 2015, mutations in CENPF were first identified as pathogenic, [2] [6] and a 2016 genetic analysis of Strømme's original two siblings found that both had mutations in both of their copies of CENPF, establishing it as the cause of the syndrome. [2] [7]
The most common symptoms of Strømme syndrome are intestinal atresia, eye abnormalities and microcephaly. However, the syndrome has a wide range of severity that generally runs in the family it presents in, ranging from only mild learning disability and microcephaly with no other features in some families [2] [6] to death in utero with severe kidney, heart, eye, skeletal, brain and intestinal malformations in others. [2] [6] [7] The variable severity is usually due to the presence or absence in each family of mutations in other genes with similar functions to CENPF. [10]
Individuals with Strømme syndrome are typically born with intestinal atresia, in which parts of the intestine are narrow or missing, leading to neonatal bowel obstruction that must be operated on. [3] The intestinal atresia is of the "apple-peel" type, an uncommon type in which the remaining portion of the intestine is found twisted around its main artery, and this usually affects the jejunum. [2] [3] Often, much of the bowel is missing in this form of atresia. [9] There can sometimes also be intestinal malrotation. [2] [3] [8] [11]
At least two individuals with the syndrome in literature have avoided intestinal atresia, one of which had a sibling with the same mutations who did not. [6] [10] In two siblings who did not survive to term, the intestinal atresia (which also included duodenal atresia) and malrotation were more severe. [2] [7]
The eyes are often smaller and underdeveloped, usually more severely in one eye than the other. [2] This can manifest as a coloboma (hole) in the iris, cataracts, opacity of the cornea (leukoma), sclerocornea (in which the white of the eye blends into the cornea), a small cornea (microcornea) and synechia (in which the iris adheres to the cornea or lens). [3] This underdevelopment of the front of the eye, known as anterior segment dysgenesis (which includes Peters' anomaly), can lead to an increased risk of glaucoma from high intraocular pressure, due to impaired eye fluid drainage, though this hadn't been reported in any of the affected individuals as of 2017 [update] . [3]
There may also be crossing of the eyes (esotropia), [8] and less commonly there may be twisted retinal blood vessels or optic nerve hypoplasia. [3] [7] The eye anomalies can result in an inability to focus (astigmatism) as well as amblyopia, in which the brain begins to fail to process input from the weaker eye during childhood. [7]
Those affected with the syndrome usually have microcephaly. [2] [3] A large minority also have pachygyria (fewer ridges in the brain) or lissencephaly (shallower ridges). [9] [10] [12] Developmental delay is usually present. It has usually been moderate-to-severe, but in some cases it has been mild. [3] A few of those affected have had increased muscle tone. [2] [5] [11] One individual had cortical heterotopia, which is a sign of impaired neuronal cell migration during neural development. [13]
Agenesis or hypoplasia of the corpus callosum and cerebellum have been found in at least one living affected individual and several who did not survive to term. [2] [6] [12] Hydrocephalus occurred in one living individual 9 months after birth [2] [5] and in four who did not survive to term. [2] [6] Hydrocephalus was also observed in zebrafish whose CENPF genes were experimentally knocked out. [2] [6] Cerebellar hypoplasia in association with hydrocephalus can constitute Dandy–Walker malformation, which is found in a number of other ciliopathies, sometimes together with agenesis of the corpus callosum. [14]
Physical features are variable but usually include short stature, large, low-set ears, a high nasal bridge, a small jaw and a large mouth. [2] [6] [10] Some of those affected have had epicanthal folds or fine, sparse hair. [5] One individual was reported to have been born with a skin tag on the left cheek. [2] [10] Four affected individuals who did not survive to term had cleft palate. [2] [6]
A minority of those affected have been born with an atrial septal defect, a type of congenital heart defect. [2] [10] One affected individual was reported to have a ventricular septal defect and neonatal peripheral oedema in the legs. [12] Two individuals who did not survive to term had a patent foramen ovale, a specific type of atrial septal defect, as well as reduced heart muscle tissue (myocardium) and abnormally small heart muscle cells (cardiomyocytes). [2] [7]
One affected individual was reported to have had hip dysplasia, leading to dislocation, [5] and another was reported to have metopic craniosynostosis, leading to a metopic ridge. [2] [10] Two individuals who did not survive to term had polydactyly of the thumb (preaxial polydactyly), flattened vertebrae (platyspondyly) and a rare chest wall malformation called a sternal cleft. [2] [7]
Two living individuals have been reported to have had underdeveloped and malformed kidneys. [12] [15] Although one was found to have normal kidneys on examination at birth, he later developed kidney failure in late adolescence and was found to have renal hypoplasia. [15] Two siblings who did not survive to term had underdeveloped kidneys and ureters, leading to a build-up of urine called hydronephrosis. [2] [7]
One affected person was reported to have a reduced number of platelets (thrombocytopaenia) in infancy, requiring transfusion. Platelets are cellular fragments formed from protrusions on megakaryocytes that enable blood clotting. Blood symptoms have not yet been reported in any other affected individuals. [12]
Strømme syndrome is caused by mutations in both copies of the CENPF gene, located on the long arm of chromosome 1. [2] [3] CENPF codes for centromere protein F. Centromere proteins are involved in the separation of chromosomes during cell division. This is through forming part of kinetochores, which are disc-shaped protein complexes that allow the centromeres of chromosomes (in the dividing form, known as chromatids) to attach to microtubules in the cell (forming what is called the spindle apparatus). This allows the microtubules to pull the chromosomes apart in the process of dividing the cell. Mutations in this gene lead to impaired cell division during early development. Mitosis has been found to take longer when CENPF is mutated. [6] [7]
Microtubules are protein structures that are part of the cytoskeleton and are necessary for cells to have diverse, complex shapes. They also aid in cell migratory ability. They are made by the centrosome, which contains a pair of cylindrical centrioles at right-angles to each other. Before division, CENPF localises at the end of one of the centrioles (the mother centriole) in order to orient microtubules correctly to form thin cellular projections called cilia. Most cilia are primary cilia, which are involved in cell signalling, sending and receiving signals to trigger cell migration, division or differentiation. Mutations in CENPF disrupt this ability to form cilia; cilia have been found to be fewer in number and shorter when CENPF is mutated. Strømme syndrome therefore falls under the classification of diseases known as ciliopathies. [2] [6]
Mutations that have been identified in CENPF have been mostly nonsense mutations, which result in the protein being cut short and usually non-functional as a result, but frameshift and splice-site mutations have also been identified. Several of the nonsense mutations that have led to this syndrome have been in exon 12 of the gene (out of 20), but mutations in other exons have been identified. [6] [7] Severity and symptoms of the syndrome have been variable regardless of the type of mutation but generally consistent within families, suggesting the severity may depend on the presence of mutations in other genes that perform similar functions to or otherwise interact with or affect CENPF (a phenomenon known as epistasis). [10] It has been suggested that an interaction between CENPF and NDE1, which causes microlissencephaly when mutated, is related to the microcephaly in Strømme syndrome. [6] [10]
Diagnosis is typically achieved by observation of symptoms; however, genetic testing provides a full confirmation. The microcephaly, intestinal atresia and some of the eye abnormalities are observable on prenatal ultrasound. [2] [4] Brain MRI scans can reveal any brain anomalies that could be associated with the syndrome. [4] Methods of genetic detection include whole exome sequencing and panel testing, which involves sequencing a selection of potential genes involved. [2] [4] [10] Sanger sequencing can confirm the nature of the mutation. [2] [10]
Once a family has been identified as being carriers for mutated CENPF genes, prenatal diagnosis and preimplantation genetic diagnosis can be offered for future conceptions. [4]
Treatment targets the symptoms. The intestinal atresia is usually surgically correctable in infancy with anastomosis; however, no eye surgery had been reported as of 2017 [update] . [3] Van Bever et al. recommended monitoring patients for glaucoma. [9] A 2021 case report reported the successful use of a kidney transplant for renal failure in one late adolescent patient. [15]
The prognosis is not yet certain. The majority of those affected have survived birth and infancy, and these individuals have continued to live through childhood and adolescence. However, a large minority with the most severe presentations have died before birth or shortly after. [4] [6] [7] The oldest known people with the syndrome, Strømme's original two siblings, who had a mild-to-moderate presentation, were in their twenties and in employment as of 2016 [update] . [2] [7]
The prevalence of the syndrome is not yet known. As of 2017 [update] , around 13 individuals had been diagnosed. [2]
The condition was first identified in 1993, when Norwegian paediatrician Petter Strømme and his associates observed two infant siblings with microcephaly and eye abnormalities alongside apple-peel intestinal atresia at Rogaland Central Hospital in Stavanger, Norway. They proposed that it constituted a new syndrome. [2] [8] Later studies by Slee and Goldblatt (1996), [5] Shanske et al. (2002), [13] Bellini et al. (2002) [11] and others observed other patients with similar symptoms who appeared to have the syndrome. [2] In 2008, Van Bever et al. proposed that the syndrome be named after Strømme, after encountering another patient who seemed to have the syndrome. [2] [9]
In 2015, Waters et al. conducted a genetic analysis on a British family in which four foetuses had miscarried with symptoms of a ciliopathy. They found that the foetuses had mutations in both copies of CENPF. They subsequently analysed a cohort of 1,000 individuals with microcephaly and found that one of them, a girl, had mutations in both of her copies of CENPF. Her learning delay was mild-to-moderate, and she did not have any other issues with her bodily systems. This confirmed for the first time that mutations in CENPF are pathogenic. [2] [6]
In 2016, Filges et al. followed up with Strømme's original two siblings and found using whole exome sequencing that they both had mutations in both of their copies of CENPF, establishing mutations in CENPF as the cause of Strømme syndrome. [2] [7]
Joubert syndrome is a rare autosomal recessive genetic disorder that affects the cerebellum, an area of the brain that controls balance and coordination.
Ellis–Van Creveld syndrome is a rare genetic disorder of the skeletal dysplasia type.
Bardet–Biedl syndrome (BBS) is a ciliopathic human genetic disorder that produces many effects and affects many body systems. It is characterized by rod/cone dystrophy, polydactyly, central obesity, hypogonadism, and kidney dysfunction in some cases. Historically, slower mental processing has also been considered a principal symptom but is now not regarded as such.
Vaginal atresia is a condition in which the vagina is abnormally closed or absent. The main causes can either be complete vaginal hypoplasia, or a vaginal obstruction, often caused by an imperforate hymen or, less commonly, a transverse vaginal septum. It results in uterovaginal outflow tract obstruction. This condition does not usually occur by itself within an individual, but coupled with other developmental disorders within the female. The disorders that are usually coupled with a female who has vaginal atresia are Mayer-Rokitansky-Küster-Hauser syndrome, Bardet-Biedl syndrome, or Fraser syndrome. One out of every 5,000 women have this abnormality.
Alström syndrome (AS), also called Alström–Hallgren syndrome, is a very rare autosomal recessive genetic disorder characterised by childhood obesity and multiple organ dysfunction. Symptoms include early-onset type 2 diabetes, cone-rod dystrophy resulting in blindness, sensorineural hearing loss and dilated cardiomyopathy. Endocrine disorders typically also occur, such as hypergonadotrophic hypogonadism and hypothyroidism, as well as acanthosis nigricans resulting from hyperinsulinemia. Developmental delay is seen in almost half of people with Alström syndrome.
Duane-radial ray syndrome, also known as Okihiro syndrome, is a rare autosomal dominant disorder that primarily affects the eyes and causes abnormalities of bones in the arms and hands. This disorder is considered to be a SALL4-related disorder due to the SALL4 gene mutations leading to these abnormalities. It is diagnosed by clinical findings on a physical exam as well as genetic testing and imaging. After being diagnosed, there are other evaluations that one may go through in order to determine the extent of the disease. There are various treatments for the symptoms of this disorder.
Papillorenal syndrome is an autosomal dominant genetic disorder marked by underdevelopment (hypoplasia) of the kidney and colobomas of the optic nerve.
Nephronophthisis is a genetic disorder of the kidneys which affects children. It is classified as a medullary cystic kidney disease. The disorder is inherited in an autosomal recessive fashion and, although rare, is the most common genetic cause of childhood kidney failure. It is a form of ciliopathy. Its incidence has been estimated to be 0.9 cases per million people in the United States, and 1 in 50,000 births in Canada.
Senior–Løken syndrome is a congenital eye disorder, first characterized in 1961. It is a rare, ciliopathic, autosomal recessive disorder characterized by juvenile nephronophthis and progressive eye disease.
Centromere protein F is a protein that in humans is encoded by the CENPF gene. It is involved in chromosome segregation during cell division. It also has a role in the orientation of microtubules to form cellular cilia.
3-M syndrome or 3M3 is a rare hereditary disorder characterized by severe growth retardation, facial dysmorphia, and skeletal abnormalities. The name 3-M is derived from the initials of the three researchers who first identified it: Miller, McKusick, and Malvaux and report their findings in the medical literature in 1972. Mutations in any one of the following three genes: CUL7, OBSL1, and CCDC8 are responsible for the occurrence of this disorder. It is inherited through an autosomal recessive pattern and considered very rare, so far less than 100 cases worldwide have been identified. Diagnosis is based on the presence of clinical features. Genetic testing can confirm the diagnosis and identify the specific gene involved. Treatment is aimed at addressing the growth and skeletal problems and may include surgical bone lengthening, adaptive aids, and physical therapy. An endocrinologist may assist with growth hormone replacement and appropriate evaluations during puberty.
A ciliopathy is any genetic disorder that affects the cellular cilia or the cilia anchoring structures, the basal bodies, or ciliary function. Primary cilia are important in guiding the process of development, so abnormal ciliary function while an embryo is developing can lead to a set of malformations that can occur regardless of the particular genetic problem. The similarity of the clinical features of these developmental disorders means that they form a recognizable cluster of syndromes, loosely attributed to abnormal ciliary function and hence called ciliopathies. Regardless of the actual genetic cause, it is clustering of a set of characteristic physiological features which define whether a syndrome is a ciliopathy.
Marden–Walker syndrome (MWS) is a rare autosomal recessive congenital disorder. It is characterized by blepharophimosis, microcephaly, micrognathia, multiple joint contractures, arachnodactyly, camptodactyly, kyphoscoliosis and delayed motor development and is often associated with cystic dysplastic kidneys, dextrocardia, Dandy–Walker malformation and agenesis of corpus callosum.
Hydrolethalus syndrome (HLS) is a rare genetic disorder that causes improper fetal development, resulting in birth defects and, most commonly, stillbirth.
MORM syndrome is an autosomal recessive congenital disorder characterized by mental retardation, truncal obesity, retinal dystrophy, and micropenis". The disorder shares similar characteristics with Bardet–Biedl syndrome and Cohen syndrome, both of which are autosomal recessive genetic disorders. MORM syndrome can be distinguished from the above disorders because symptoms appear at a young age. The disorder is not dependent on sex of the offspring, both male and female offspring are equally likely to inherit the disorder.
Goldberg–Shprintzen syndrome is a very rare connective tissue condition associated with mutations in KIAA1279 gene which encodes KIF-binding protein (KBP), a protein that may interact with microtubules and actin filaments. KBP may play a key role in cytoskeleton formation and neurite growth.
Genitopatellar syndrome is a rare disorder consisting of congenital flexion contractures of the lower extremities, abnormal or missing patellae, and urogenital anomalies. Additional symptoms include microcephaly, severe psychomotor disability. In 2012, it was shown that mutations in the gene KAT6B cause the syndrome. Genitopatellar syndrome (GTPTS) can be caused by heterozygous mutation in the KAT6B gene on chromosome 10q22. The Say-Barber-Biesecker variant of Ohdo syndrome, which has many overlapping features with GTPTS, can also be caused by heterozygous mutation in the KAT6B gene.
Ciliogenesis is defined as the building of the cell's antenna or extracellular fluid mediation mechanism. It includes the assembly and disassembly of the cilia during the cell cycle. Cilia are important appendages of cells and are involved in numerous activities such as cell signaling, processing developmental signals, and directing the flow of fluids such as mucus over and around cells. Due to the importance of these cell processes, defects in ciliogenesis can lead to numerous human diseases related to non-functioning cilia known as ciliopathies.
Okamoto syndrome (OS), also known as Au–Kline syndrome (AKS), is a very rare autosomal dominant genetic condition characterised by congenital hydronephrosis, low muscle tone, heart defects, intellectual disability and characteristic facial features. Those affected often have neurological and skeletal abnormalities, as well as frequent urinary tract infections. Language and walking are usually delayed. Facial features include prominent, downturned ears, an open, downturned mouth and drooping eyelids (ptosis).
Mandibulofacial dysostosis with microcephaly syndrome, also known as growth delay-intellectual disability-mandibulofacial dysostosis-microcephaly-cleft palate syndrome, mandibulofacial dysostosis, guion-almeida type, or simply as MFDM syndrome is a rare genetic disorder which is characterized by developmental delays, intellectual disabilities, and craniofacial dysmorphisms.